Kamada
is an Israel-based biopharmaceutical company that discovers and develops protein-derived therapeutics for the treatment of AATD and infectious diseases... Read moreKamada
is an Israel-based biopharmaceutical company that discovers and develops protein-derived therapeutics for the treatment of AATD and infectious diseases... Read more
News
Aug 12, 2026
Nasdaq
Kamada: Kamada CFO Chaime Orlev To Step Down
Aug 12, 2026
Yahoo
Kamada: Kamada Reports Record-High First Half and Second Quarter 2026 Financial Results, Representing Double-Digit Profitable Growth and the Strongest in Kamada's History; Affirms 2026 Annual Guidance
Aug 12, 2026
Yahoo
Kamada: Kamada Announces Planned Transition of Chief Financial Officer
Aug 06, 2026
Benzinga
Kamada: Insider Decision Making Waves At Kamada: David Tsur Exercises Options, Realizing $0
Jul 20, 2026
FinanzNachrichten
Kamada: Kamada Ltd.: Kamada Announces a Three-Year $50 Million Sales Agreement to Supply Plasma to a Leading Biopharmaceutical Company focused on Plasma-derived Therapies
Jun 01, 2026
Nasdaq
Kamada: Kamada Receives FDA Approval For In-House Rabies Virus Neutralization Testing Laboratory
May 13, 2026
Benzinga
Kamada: Kamada Q1 2026 Earnings Call: Complete Transcript
May 13, 2026
Benzinga
Kamada: Kamada Q1 EPS $0.07 Misses $0.12 Estimate, Sa...
May 06, 2026
Benzinga
Kamada: Kamada to Announce First Quarter 2026 Financial Results on May 13, 2026
Apr 10, 2026
Benzinga
Kamada: Chaime Orlev At Kamada Secures Company Stock Options: $417K Acquired
